Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | ATRA | FIMM | pan-cancer | AAC | 0.086 | 0.6 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |